Re: Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: A comparative study

European Urology

Volumn 61, Issue 6, 2012, Pages 1266-1267

  Van Der Poel, Henk G ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CYSTECTOMY; EXTENDED LYMPH NODE DISSECTION; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SUPER EXTENDED LYMPH NODE DISSECTION; TREATMENT OUTCOME;

EID: 84860290963     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.03.029     Document Type: Note

References (2)

1. S.F. Shariat, B. Ehdaie, and M. Rink Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment Eur Urol 61 2012 237 242
2. B. Roth, M.P. Wissmeyer, and P. Zehnder A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder Eur Urol 57 2010 205 211